258 Scientific correlatives from LCCC 1525: a phase II study of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer

Ítems similars

• 258 Scientific correlatives from LCCC 1525: a phase II study of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer
  per: Benjamin Vincent, et al.
  Publicat: (2020-11-01)
• The Scots in Java, 1811-1816. An Episode from the History of the 78th Regiment of Foot (Ross-shire Buffs): The Storming of the Yogyakarta Court, 20 June 1812, and its aftermath
  per: (†), E. Edwards McKinnon, et al.
  Publicat: (2024)
• Comprehensive Analysis of the Immunogenomics of Triple-Negative Breast Cancer Brain Metastases From LCCC1419
  per: Eric D. Routh, et al.
  Publicat: (2022-07-01)
• A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer
  per: Natalia Mitin, et al.
  Publicat: (2022-09-01)
• A phase II single‐arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and preliminary effects
  per: Zev M. Nakamura, et al.
  Publicat: (2023-04-01)